---
title: "Why This Top-Notch Trio Of Biotech Stocks Just Took A Tumble"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294713077.md"
description: "Leading biotech companies TG Therapeutics and Twist Bioscience experienced significant declines on Monday following the release of their second-quarter reports. The stocks of these top-performing companies dropped due to mixed results. The sudden fall in value has raised concerns among investors, as these companies were previously considered top-notch in the biotech sector."
datetime: "2026-08-03T15:02:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294713077.md)
  - [en](https://longbridge.com/en/news/294713077.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294713077.md)
generator: "portal-rs"
---

# Why This Top-Notch Trio Of Biotech Stocks Just Took A Tumble

Leading biotech companies TG Therapeutics and Twist Bioscience experienced significant declines on Monday following the release of their second-quarter reports. The stocks of these top-performing companies dropped due to mixed results. The sudden fall in value has raised concerns among investors, as these companies were previously considered top-notch in the biotech sector.

### Related Stocks

- [TGTX.US](https://longbridge.com/en/quote/TGTX.US.md)
- [TWST.US](https://longbridge.com/en/quote/TWST.US.md)

## Related News & Research

- [Twist Bioscience CEO Emily M. Leproust disposes of 5,203 common shares worth $921,493.96](https://longbridge.com/en/news/300161715.md)
- [BUZZ-Leerink sees life-science tools benefiting from Anthropic's push into biology](https://longbridge.com/en/news/300019173.md)
- [Twist Bioscience CEO Emily M. Leproust disposes of USD 51.47 million in common shares](https://longbridge.com/en/news/299679006.md)
- [Twist Bioscience (NASDAQ:TWST) Hits New 1-Year High - What's Next?](https://longbridge.com/en/news/300392588.md)
- [Insider Decision: Laurence N Charney Offloads $274K Worth Of TG Therapeutics Stock](https://longbridge.com/en/news/299069037.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**